Royalty Report: Medical, Device, Surgical – Collection: 2717


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 6


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6

Primary Industries

  • Medical
  • Device
  • Surgical

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 2717

License Grant
The Licensor grants an exclusive license to use the licensed patents and to manufacture and sell the licensed inventions to the Licensee . The Licensee shall assume Licensor's FDA 510K approvals on the licensed inventions and the respective processes. The exclusive license conveyed in this Agreement shall be exercisable throughout the United States, its territories and possessions, and in all foreign countries.
License Property
The Licensor is the owner of the entire right, title and interest in the following Cathlab and balloon cardiovascular inventions letters patent of the United States with the indicated patent numbers, issuance dates, and expiration  dates

1.1 Embolectomy Catheters
1.2 Bi-Lumen Irrigation Catheters
1.3 Occlusion Catheters
1.4 Biliary Catheters
1.5 Termodilution Catheters
1.6 Angiographic/Angioscopic Catheters
1.7 Ahn Thrombectomy Catheters

All of the catheters listed above are variations of the following patents of 4,670,313 and 4,690,844.

IPSCIO Record ID: 1099

License Grant
Licensor, an individual, hereby assigns to Licensee his entire right, title and interest in and to all patents and copyrights, trade secrets, know-how, and other intellectual property rights which relate to the Field and which exist now or at any time prior to the expiration of the term of the Consulting Agreement.
License Property
'Products' shall mean valved tip angiographic and infusion catheters that incorporate U.S. Patent #5,085,635.
Field of Use
'Field of Interest' and 'Field' shall mean products and methods related to the concept embodied in the Products of a valved tip to allow injection or infusion of fluids in the body.

IPSCIO Record ID: 2991

License Grant
Trial in the Company's U.S. case based on the Kastenhofer patent in Federal District Court in California concluded in October 2007 with a jury finding that the patent was invalid. The licensee was found to infringed a patent covering features of the chemically treated and multi-layered guide wire tubes that enable catheters to slide into place. The jury also found for patent owner on its counterclaim that sale by the Company of its balloon catheters and stent delivery systems infringe owner's Fontirroche patent. The Court has denied the Company's post trial motions.
License Property
Fontirroche patents pertain to designs for balloon catheters and stent delivery systems.

IPSCIO Record ID: 2663

License Grant
Seller, an individual, hereby sells, assigns, transfers and conveys to Purchaser all right, title and interest it has in and to the Patents and all inventions and discoveries described therein, including without limitation, all rights of Seller under the Assignment Agreement, and all rights of Seller to collect royalties under such Patents.
License Property
The Licensor (Seller) wishes to sell to the Licensee (Purchaser) all right, title and interest in the Patents 5,476,450. Apparatus and Method for Aspirating Intravascular, Pulmonary and Cardiac Obstructions.

IPSCIO Record ID: 27674

License Grant
The Licensor hereby grants to the Company and its Affiliates an exclusive, worldwide right under the Patent Rights and Related Materials in the Company's Field of Use to (i) design, develop, make, have made, use, sell, offer for sale, import, export or otherwise distribute products in the Company's Field of Use, and (ii) practice or authorize the practice of any method, process, or procedure in the Company's Field of Use.
License Property
Patents relate to applying radiofrequency energy to tissue.

United States Patent No. 5,057,105

United States Patent No. RE 35,330

Australian Patent No.  633358

Canadian Patent No. 2,065,261

European Regional Patent No. 489,814 (in effect in Germany, France, Great Britain, Italy)

Field of Use
The Company's Field of Use shall mean the Gastro-Intestinal Tract in the medical industry.

IPSCIO Record ID: 3990

License Grant
The Foundation owns the Licensable Technology as defined. The Optionee specializes in developing technology and bringing new technologies to market; and desires to investigate and conduct due diligence with respect to the commercial viability of the Licensable Technology prior to executing the License Agreement.
License Property
'Licensable Patents' shall refer to and mean US Patent Application # 60/797,433 entitled 'Intra-jugular Catheter' and any U.S. or foreign patent applications, reissues, extensions, renewals, reexaminations, certificates of invention, substitutions, divisions, continuations, and continuations-in-part thereof having the Principal Investigator as an inventor and having the same priority date as the parent applications. The Field shall mean clinical use as a catheter for insertion into the vascular system of a patient to direct fluid flow, sampling of fluids and oxygenation monitoring.
Field of Use
'Field' shall mean clinical use as a catheter for insertion into the vascular system of a patient to direct fluid flow, sampling of fluids and oxygenation monitoring.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.